Clinical Trials Browser

Phase 3 × NIH × Anal Canal Carcinoma × Clear all

NCT03233711 2026-03-18

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Phase 3 Active not recruiting

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00025090 2013-08-26

Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer

Phase 3 Completed

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms